粪便免疫化学试验阳性患者中癌前病变和恶性病变的频率和模式。

Mymensingh medical journal : MMJ Pub Date : 2025-07-01
C S Hyder, M A Uddin, M T Jalal, S S Karim, M A Taher, K Nahar, M S Hossain, M S H Sheikh, M S Islam
{"title":"粪便免疫化学试验阳性患者中癌前病变和恶性病变的频率和模式。","authors":"C S Hyder, M A Uddin, M T Jalal, S S Karim, M A Taher, K Nahar, M S Hossain, M S H Sheikh, M S Islam","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Colorectal cancer is a challenging clinical entity worldwide. Adenomatous polyps are considered precursors to cancer. Detection and confirmation of mucosal healing of ulcerative colitis require a colonoscopy. For early detection of polyps or ulcers, different screening investigations like colonoscopy, Fecal Immunochemistry Test, gFOBT, CT colonography, etc. are used. Though gold standard colonoscopy has both diagnostic and therapeutic roles, Fecal Immunochemistry Test can detect advanced adenoma or established cancer or mucosal status of Ulcerative colitis. The Fecal Immunochemistry Test is a less expensive technique for the early detection of colonic pathology and is suitable for our demographic. The aim of the study was to observe the frequency and pattern of premalignant and malignant lesions among Fecal Immunochemical Test (FIT) positive patients. This observational cross-sectional study was conducted from July 2019 to June 2020 among 105 Fecal Immunochemical Test (FIT) positive patients. The observational cross-sectional study was carried out in the Department of Colorectal Surgery, Bangabandhu Sheikh Mujib Medical University and some private hospitals, Bangladesh. FIT tests were done in ICDDR`B. Among 105 Fecal immunochemical test positive study patients, colonoscopy evaluations were done. Among these, 58 cases (55.2%) revealed different types of polyps. Pedunculated polyps 42(40.0%) were predominant, present in 42(40.0%) of patients. Other than polyps, there were ulcers 14(13.3%), malignant looking growth 3(2.9%), hemorrhoid 13(12.4%) and normal findings in 15(14.3%) cases. The age range was 40-70 years. The mean age was 51.73±7.97 years. Adenomatous polyps and malignancies were 47(44.7%) and 5(4.8%). Advanced adenomas were 11(10.4%) cases. Thirty six (62.1%) polyps were in the left colon. Patients with normal findings, diverticulosis and hemorrhoids had not undergone biopsy. Fecal immunochemical test (FIT) can predominantly detect adenomas, especially advanced adenoma and precursor lesions. The study finding showed that both non-neoplastic, neoplastic polyps and ulcers had occult bleeding. So, they became FIT positive. Though colonoscopy is the gold standard in the detection of polyps, ulcers, or malignant lesions, FIT can be a good supportive tool for screening.</p>","PeriodicalId":94148,"journal":{"name":"Mymensingh medical journal : MMJ","volume":"34 3","pages":"745-751"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Frequency and Pattern of Premalignant and Malignant Lesions among Fecal Immunochemical Test Positive Patients.\",\"authors\":\"C S Hyder, M A Uddin, M T Jalal, S S Karim, M A Taher, K Nahar, M S Hossain, M S H Sheikh, M S Islam\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Colorectal cancer is a challenging clinical entity worldwide. Adenomatous polyps are considered precursors to cancer. Detection and confirmation of mucosal healing of ulcerative colitis require a colonoscopy. For early detection of polyps or ulcers, different screening investigations like colonoscopy, Fecal Immunochemistry Test, gFOBT, CT colonography, etc. are used. Though gold standard colonoscopy has both diagnostic and therapeutic roles, Fecal Immunochemistry Test can detect advanced adenoma or established cancer or mucosal status of Ulcerative colitis. The Fecal Immunochemistry Test is a less expensive technique for the early detection of colonic pathology and is suitable for our demographic. The aim of the study was to observe the frequency and pattern of premalignant and malignant lesions among Fecal Immunochemical Test (FIT) positive patients. This observational cross-sectional study was conducted from July 2019 to June 2020 among 105 Fecal Immunochemical Test (FIT) positive patients. The observational cross-sectional study was carried out in the Department of Colorectal Surgery, Bangabandhu Sheikh Mujib Medical University and some private hospitals, Bangladesh. FIT tests were done in ICDDR`B. Among 105 Fecal immunochemical test positive study patients, colonoscopy evaluations were done. Among these, 58 cases (55.2%) revealed different types of polyps. Pedunculated polyps 42(40.0%) were predominant, present in 42(40.0%) of patients. Other than polyps, there were ulcers 14(13.3%), malignant looking growth 3(2.9%), hemorrhoid 13(12.4%) and normal findings in 15(14.3%) cases. The age range was 40-70 years. The mean age was 51.73±7.97 years. Adenomatous polyps and malignancies were 47(44.7%) and 5(4.8%). Advanced adenomas were 11(10.4%) cases. Thirty six (62.1%) polyps were in the left colon. Patients with normal findings, diverticulosis and hemorrhoids had not undergone biopsy. Fecal immunochemical test (FIT) can predominantly detect adenomas, especially advanced adenoma and precursor lesions. The study finding showed that both non-neoplastic, neoplastic polyps and ulcers had occult bleeding. So, they became FIT positive. Though colonoscopy is the gold standard in the detection of polyps, ulcers, or malignant lesions, FIT can be a good supportive tool for screening.</p>\",\"PeriodicalId\":94148,\"journal\":{\"name\":\"Mymensingh medical journal : MMJ\",\"volume\":\"34 3\",\"pages\":\"745-751\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mymensingh medical journal : MMJ\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mymensingh medical journal : MMJ","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

结直肠癌是世界范围内具有挑战性的临床疾病。腺瘤性息肉被认为是癌症的前兆。发现和确认溃疡性结肠炎的粘膜愈合需要结肠镜检查。为了早期发现息肉或溃疡,不同的筛查调查如结肠镜检查,粪便免疫化学测试,gobt, CT结肠镜检查等。虽然金标准结肠镜检查具有诊断和治疗双重作用,但粪便免疫化学测试可以检测溃疡性结肠炎的晚期腺瘤或已确定的癌症或粘膜状态。粪便免疫化学测试是一种较便宜的技术,用于结肠病理的早期检测,适合我们的人口。本研究的目的是观察粪便免疫化学试验(FIT)阳性患者的癌前病变和恶性病变的频率和模式。这项观察性横断面研究于2019年7月至2020年6月在105名粪便免疫化学测试(FIT)阳性患者中进行。本观察性横断面研究在孟加拉国Bangabandhu Sheikh Mujib医科大学结直肠外科和一些私立医院进行。ICDDR 'B组进行FIT试验。105例粪便免疫化学试验阳性患者行结肠镜检查。其中58例(55.2%)出现不同类型的息肉。带蒂息肉42例(40.0%)占多数,42例(40.0%)存在。除息肉外,溃疡14例(13.3%),恶性生长3例(2.9%),痔疮13例(12.4%),正常15例(14.3%)。年龄范围为40-70岁。平均年龄51.73±7.97岁。腺瘤性息肉47例(44.7%),恶性肿瘤5例(4.8%)。晚期腺瘤11例(10.4%)。36例(62.1%)息肉位于左结肠。结果正常、憩室病和痔疮患者未行活检。粪便免疫化学试验(FIT)主要用于检测腺瘤,特别是晚期腺瘤和前驱病变。研究结果显示,非肿瘤性、肿瘤性息肉和溃疡均有隐蔽性出血。所以,他们变成了FIT阳性。虽然结肠镜检查是检测息肉、溃疡或恶性病变的金标准,但FIT可以作为筛查的良好辅助工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Frequency and Pattern of Premalignant and Malignant Lesions among Fecal Immunochemical Test Positive Patients.

Colorectal cancer is a challenging clinical entity worldwide. Adenomatous polyps are considered precursors to cancer. Detection and confirmation of mucosal healing of ulcerative colitis require a colonoscopy. For early detection of polyps or ulcers, different screening investigations like colonoscopy, Fecal Immunochemistry Test, gFOBT, CT colonography, etc. are used. Though gold standard colonoscopy has both diagnostic and therapeutic roles, Fecal Immunochemistry Test can detect advanced adenoma or established cancer or mucosal status of Ulcerative colitis. The Fecal Immunochemistry Test is a less expensive technique for the early detection of colonic pathology and is suitable for our demographic. The aim of the study was to observe the frequency and pattern of premalignant and malignant lesions among Fecal Immunochemical Test (FIT) positive patients. This observational cross-sectional study was conducted from July 2019 to June 2020 among 105 Fecal Immunochemical Test (FIT) positive patients. The observational cross-sectional study was carried out in the Department of Colorectal Surgery, Bangabandhu Sheikh Mujib Medical University and some private hospitals, Bangladesh. FIT tests were done in ICDDR`B. Among 105 Fecal immunochemical test positive study patients, colonoscopy evaluations were done. Among these, 58 cases (55.2%) revealed different types of polyps. Pedunculated polyps 42(40.0%) were predominant, present in 42(40.0%) of patients. Other than polyps, there were ulcers 14(13.3%), malignant looking growth 3(2.9%), hemorrhoid 13(12.4%) and normal findings in 15(14.3%) cases. The age range was 40-70 years. The mean age was 51.73±7.97 years. Adenomatous polyps and malignancies were 47(44.7%) and 5(4.8%). Advanced adenomas were 11(10.4%) cases. Thirty six (62.1%) polyps were in the left colon. Patients with normal findings, diverticulosis and hemorrhoids had not undergone biopsy. Fecal immunochemical test (FIT) can predominantly detect adenomas, especially advanced adenoma and precursor lesions. The study finding showed that both non-neoplastic, neoplastic polyps and ulcers had occult bleeding. So, they became FIT positive. Though colonoscopy is the gold standard in the detection of polyps, ulcers, or malignant lesions, FIT can be a good supportive tool for screening.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信